SCHEMBL13643293

SCHEMBL13643293

Clc1cc(Cl)c2cc(-c3ccc4ccccc4c3)c3ccccc3c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 1/20 0.42
ALDH1A1 P00352 2/20 0.41
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
CCR1 P32246 1/20 0.38
CCR8 P51685 1/20 0.38
DHFR P00374 1/20 0.38
KDM4E B2RXH2 1/20 0.37
PTGES O14684 1/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13643295 0.87 CYP1A2 (0.44) GSTP1L3MBTL1MAPTALDH1A1ESR1
SCHEMBL13643297 0.84 ALDH1A1 (0.43) L3MBTL1MAPTALDH1A1ESR1ESR2
SCHEMBL13643302 0.82 CYP11B1 (0.41) GSTP1L3MBTL1MAPTALDH1A1ESR1
SCHEMBL13643282 0.81 NPC1 (0.46) L3MBTL1MAPTALDH1A1KDM4ECYP1A2
SCHEMBL13643279 0.80 ALDH1A1 (0.44) L3MBTL1MAPTALDH1A1CCR1CCR8
SCHEMBL13643300 0.78 L3MBTL1 (0.44) L3MBTL1MAPTALDH1A1CCR1CCR8
SCHEMBL13643290 0.77 ALDH1A1 (0.43) L3MBTL1MAPTALDH1A1CCR1CCR8
SCHEMBL17508354 0.76 GSTP1 (0.46) GSTP1MAPTALDH1A1ESR1ESR2
SCHEMBL29498093 0.75 MAPT (0.69) L3MBTL1MAPTALDH1A1CCR1CCR8
SCHEMBL8140334 0.75 MAPT (0.69) L3MBTL1MAPTALDH1A1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 GSTP1 1236/4885L3MBTL1 1339/4885MAPT 859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.